Logo image of HEMP.CA

HEMPALTA CORP (HEMP.CA) Stock Fundamental Analysis

TSX-V:HEMP - TSX Venture Exchange - CA42371M1041 - Common Stock - Currency: CAD

0.05  0 (-9.09%)

Fundamental Rating

1

Taking everything into account, HEMP scores 1 out of 10 in our fundamental rating. HEMP was compared to 0 industry peers in the Unkown industry. HEMP has a bad profitability rating. Also its financial health evaluation is rather negative. HEMP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HEMP has reported negative net income.
HEMP had a negative operating cash flow in the past year.
HEMP.CA Yearly Net Income VS EBIT VS OCF VS FCFHEMP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -99.77%
ROE -144.13%
ROIC N/A
ROA(3y)-46.23%
ROA(5y)N/A
ROE(3y)-71.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEMP.CA Yearly ROA, ROE, ROICHEMP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -50 -100 -150

1.3 Margins

HEMP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HEMP.CA Yearly Profit, Operating, Gross MarginsHEMP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

2

2. Health

2.1 Basic Checks

HEMP does not have a ROIC to compare to the WACC, probably because it is not profitable.
HEMP has more shares outstanding than it did 1 year ago.
The debt/assets ratio for HEMP is higher compared to a year ago.
HEMP.CA Yearly Shares OutstandingHEMP.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M
HEMP.CA Yearly Total Debt VS Total AssetsHEMP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

HEMP has an Altman-Z score of -0.54. This is a bad value and indicates that HEMP is not financially healthy and even has some risk of bankruptcy.
HEMP has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -0.54
ROIC/WACCN/A
WACC8.27%
HEMP.CA Yearly LT Debt VS Equity VS FCFHEMP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M -2M 3M

2.3 Liquidity

HEMP has a Current Ratio of 5.18. This indicates that HEMP is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 4.36 indicates that HEMP has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5.18
Quick Ratio 4.36
HEMP.CA Yearly Current Assets VS Current LiabilitesHEMP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

HEMP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3720.00%.
EPS 1Y (TTM)-3720%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55333.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HEMP.CA Yearly Revenue VS EstimatesHEMP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 100K 200K 300K 400K 500K
HEMP.CA Yearly EPS VS EstimatesHEMP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

HEMP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HEMP.CA Price Earnings VS Forward Price EarningsHEMP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HEMP.CA Per share dataHEMP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HEMP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEMPALTA CORP

TSX-V:HEMP (3/7/2025, 7:00:00 PM)

0.05

0 (-9.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners20.83%
Ins Owner ChangeN/A
Market Cap4.75M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.2
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.01
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -99.77%
ROE -144.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.23%
ROA(5y)N/A
ROE(3y)-71.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.4%
Cap/Sales 89.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.18
Quick Ratio 4.36
Altman-Z -0.54
F-Score2
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3720%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55333.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3781.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5671.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4439.2%
OCF growth 3YN/A
OCF growth 5YN/A